Literature DB >> 27171485

Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.

Ketan Patel1, Ravi Doddapaneni1, Nusrat Chowdhury1, Cedar Ha Boakye1, Gautam Behl1, Mandip Singh1.   

Abstract

AIM: Therapeutic efficacy of anticancer nanomedicine is compromised by tumor stromal barriers. The present study deals with the development of docetaxel loaded PEGylated liposomes (DTXPL) and to investigate the effect of tumor stroma disrupting agent, telmisartan, on anticancer efficacy of DTXPL.
METHODS: DTXPL was prepared using proprietary modified hydration method. Effect of oral telmisartan treatment on tumor uptake of coumarin-6 liposomes and anticancer efficacy of DTXPL was evaluated in orthotopic xenograft lung tumor bearing mice.
RESULTS: DTXPL (105.7 ± 3.8 nm) showed very high physical stability, negligible hemolysis, 428% enhancement in bioavailability with significantly higher intratumoral uptake. Marked reduction in collagen-I, MMP2/9 and lung tumor weight were observed in DTXPL+telmisartan group.
CONCLUSION: Combination of DTXPL with telmisartan could significantly enhance clinical outcome in lung cancer.

Entities:  

Keywords:  cancer nanomedicine; docetaxel; orthotopic lung cancer; pegylated liposome; solid tumor targeting; tumor fibrosis; tumor stroma

Mesh:

Substances:

Year:  2016        PMID: 27171485      PMCID: PMC4910941          DOI: 10.2217/nnm.16.37

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  43 in total

1.  Effect of liposome type and membrane fluidity on drug-membrane partitioning analyzed by immobilized liposome chromatography.

Authors:  X Y Liu; Q Yang; N Kamo; J Miyake
Journal:  J Chromatogr A       Date:  2001-04-13       Impact factor: 4.759

2.  Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.

Authors:  Rachel de Oliveira; Pengxiang Zhao; Na Li; Luiz Claudio de Santa Maria; Juliette Vergnaud; Jaime Ruiz; Didier Astruc; Gillian Barratt
Journal:  Int J Pharm       Date:  2013-05-21       Impact factor: 5.875

Review 3.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.

Authors:  Kazuo Maruyama
Journal:  Adv Drug Deliv Rev       Date:  2010-10-28       Impact factor: 15.470

4.  Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix.

Authors:  Mathumai Kanapathipillai; Akiko Mammoto; Tadanori Mammoto; Joo H Kang; Elisabeth Jiang; Kaustabh Ghosh; Netanel Korin; Ashley Gibbs; Robert Mannix; Donald E Ingber
Journal:  Nano Lett       Date:  2012-05-10       Impact factor: 11.189

5.  Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.

Authors:  Nkechi Ichite; Mahavir B Chougule; Tanise Jackson; Suniket V Fulzele; Stephen Safe; Mandip Singh
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 6.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

7.  Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes.

Authors:  Lingyun Zhao; Si-Shen Feng
Journal:  J Colloid Interface Sci       Date:  2004-06-01       Impact factor: 8.128

Review 8.  Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review).

Authors:  Panagiotis Papageorgis; Triantafyllos Stylianopoulos
Journal:  Int J Oncol       Date:  2015-01-07       Impact factor: 5.650

Review 9.  Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.

Authors:  Su-Eon Jin; Hyo-Eon Jin; Soon-Sun Hong
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

10.  Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.

Authors:  Vikash P Chauhan; John D Martin; Hao Liu; Delphine A Lacorre; Saloni R Jain; Sergey V Kozin; Triantafyllos Stylianopoulos; Ahmed S Mousa; Xiaoxing Han; Pichet Adstamongkonkul; Zoran Popović; Peigen Huang; Moungi G Bawendi; Yves Boucher; Rakesh K Jain
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  17 in total

1.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

2.  Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Mandip Singh
Journal:  Colloids Surf B Biointerfaces       Date:  2017-01-23       Impact factor: 5.268

3.  Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.

Authors:  Nusrat Chowdhury; Imran Vhora; Ketan Patel; Ravi Doddapaneni; Arindam Mondal; Mandip Singh
Journal:  Pharm Res       Date:  2017-09-05       Impact factor: 4.200

Review 4.  Role of Exosomes for Delivery of Chemotherapeutic Drugs.

Authors:  Aragaw Gebeyehu; Nagavendra Kommineni; David G Meckes; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

5.  Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique.

Authors:  Arvind Bagde; Emmanual Kouagou; Mandip Singh
Journal:  AAPS PharmSciTech       Date:  2022-09-16       Impact factor: 4.026

6.  Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.

Authors:  Shallu Kutlehria; Gautam Behl; Ketan Patel; Ravi Doddapaneni; Imran Vhora; Nusrat Chowdhury; Arvind Bagde; Mandip Singh
Journal:  AAPS PharmSciTech       Date:  2017-10-10       Impact factor: 3.246

7.  Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts.

Authors:  Peggy Arthur; Nilkumar Patel; Sunil Kumar Surapaneni; Arindam Mondal; Aragaw Gebeyehu; Arvind Bagde; Shallu Kutlehria; Ebony Nottingham; Mandip Singh
Journal:  Toxicol Appl Pharmacol       Date:  2020-06-12       Impact factor: 4.219

8.  Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro.

Authors:  Richa Vartak; Suyash M Patil; Aishwarya Saraswat; Manali Patki; Nitesh K Kunda; Ketan Patel
Journal:  Nanomedicine (Lond)       Date:  2021-05-13       Impact factor: 5.307

9.  Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer.

Authors:  Sunil Kumar Surapaneni; Ebony Nottingham; Arindam Mondal; Nilkumar Patel; Peggy Arthur; Aragaw Gebeyehu; Anil Kumar Kalvala; Arun K Rishi; Mandip Singh
Journal:  Anticancer Res       Date:  2021-09-01       Impact factor: 2.480

10.  Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.

Authors:  Ravi Doddapaneni; Ketan Patel; Nusrat Chowdhury; Mandip Singh
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.